🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

RecruitingPhase 3Ages any - 1 MonthAllSherief Abd-Elsalam
NCT03949049 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * neonates with hypoxia. Exclusion Criteria: * hypoxic ischemic encephalopathy
💊

What it tests

  • Citicoline
  • Placebo
📍

Where

1 site
Sherief Abd-Elsalam
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy